Refining neoadjuvant immunotherapy for resectable lung cancer. Shields MD, Lovly CM. Nat Med 2024 May 13. doi: 10.1038/s41591-024-03001.

Read + Share

Amedeo Smart

Independent Medical Education

Shields MD, Lovly CM. Refining neoadjuvant immunotherapy for resectable lung cancer. Nat Med 2024 May 13. doi: 10.1038/s41591-024-03001.
PMID: 38740995